Evidence map›Paper›PMID 35717197›Full record

ArticleBMC endocrine disorders2022

Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh.

Mohammod Feroz Amin, Bishwajit Bhowmik, Rozana Rouf, Monami Islam Khan, Syeda Anika Tasnim, Faria Afsana, Rushda Sharmin, Kazi Nazmul Hossain, Md Abdullah Saeed Khan, Samiha Mashiat Amin and 3 more

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia-Pacific Region.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammod Feroz AminDepartment of Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh. feroz_amin@yahoo.com.
Bishwajit BhowmikDiabetic Association of Bangladesh, Centre for Global Health Research, Dhaka, 1000 , Bangladesh.
Rozana RoufSquare Hospital, Dhaka, Bangladesh.
Monami Islam KhanDepartment of Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh.
Syeda Anika TasnimDoctors in Life, Dhaka, 1000, Bangladesh.
Faria AfsanaDepartment of Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh.
Rushda SharminDepartment of Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh.
Kazi Nazmul HossainDepartment of Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh.
Md Abdullah Saeed KhanPi Research Consultancy Center, Dhaka, 1211, Bangladesh.
Samiha Mashiat AminShere Bangla Medical College, Barishal, Bangladesh.
Md Shek Sady KhanBangladesh University of Health Science, Mirpur, Dhaka, Bangladesh.
Md Faruque PathanBIRDEM Academy, Dhaka, 1000, Bangladesh.
Mohammad Jahid HasanPi Research Consultancy Center, Dhaka, 1211, Bangladesh. dr.jahid61@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) is rising at a rapid rate worldwide. As a chronic, incurable metabolic disease, diabetes affects a person's life in all ways. Studies thus far have focused on the impact of diabetes on the physical and mental health of persons affected by the quality of life (QoL). This study aimed to explore the whole range of QoL deficits using the World Health Organization Quality of Life brief version (WHOQOL-BREF) in type-2 diabetic patients.

methodsThis cross-sectional study was carried out among individuals aged at or above 15 years with type 2 diabetes (T2DM). Patients with prior mental health illness and unwillingness to give consent were excluded. A pretested structured questionnaire including the 26-item WHOQOL-BREF questionnaire was used for face-to-face interviews. Appropriate ethical measures were ensured. All statistical analyses were carried out using the statistical software STATA (Version 16.1). Graphs were created using R (Version 4.0.0).

resultsA total of 500 T2 DM patients with a mean age of 55.8 ± 13.2 years (± SD) and a female proportion of 50.8% were included. Overall, 22.2% of participants rated their QoL as poor, and 25% were dissatisfied with their health (as assessed by questions 1 and 2 of the WHOQOL-BREF questionnaire). More than half (54% and 51.2%, respectively) had an average evaluation of their QoL and health. The QoL scores were below average, with mean scores (± SD) for the physical health, psychological, social relationship, and environmental domains of 37.2 ± 20.5, 44.2 ± 21.0, 39.6 ± 23.2, and 41.6 ± 19.5, respectively. Multiple regression analysis revealed that the patient's level of education and monthly family income were significant positive modifiers and that complications (nephropathy, retinopathy, and peripheral artery disease) were significant negative determinants of the QoL score in different domains.

conclusionThis study found the overall quality of life among T2DM patients below average. Health authorities and clinicians should take these findings into account and incorporate necessary measures to ameliorate negative modifiers of the quality of life of sufferers.

Indexed as

Diabetes Mellitus, Type 2Quality of LifeAdultAgedBangladeshCross-Sectional StudiesFemaleHumansMiddle AgedSurveys and QuestionnairesDiabetic complicationsQuality of lifeType-2 diabetes mellitusWHOQOL-BREF

Identifiers

PMID35717197
PMCPMC9206302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.